The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
Share
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
DOE Launches $17.5 Billion Nuclear Effort Amid AI Power Demand
A financing program seeks to accelerate nuclear projects as electricity demand grows from data centers, manufacturing and national security.
3m read -
VA Pilot Shows Value of AI-Powered VR Training
A VA proof-of-concept pilot is demonstrating how AI-enabled virtual reality training boosts knowledge scores and lowers training costs.
3m read -
AI Powers Smithsonian’s Digital Transformation for America250
The Smithsonian is applying AI to research, digital collections and visitor experiences as it prepares for America250.
12m listen -
The Value of Data Readiness in Federal AI Adoption
Michael Anderson discusses the importance of data readiness for AI and how organizations can build strong data foundations to accelerate adoption.
12m watch
